Bank of America’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$142K Buy
98,095
+5,674
+6% +$8.99K ﹤0.01% 5458
2025
Q4
$128K Sell
92,421
-22,247
-19% -$46.6K ﹤0.01% 5531
2025
Q3
$313K Buy
114,668
+31,353
+38% +$111K ﹤0.01% 6059
2025
Q2
$291K Sell
83,315
-170,269
-67% -$672K ﹤0.01% 6006
2025
Q1
$933K Buy
253,584
+186,430
+278% +$681K ﹤0.01% 5271
2024
Q4
$108K Sell
67,154
-797
-1% -$828 ﹤0.01% 6361
2024
Q3
$51.6K Sell
67,951
-1
-0% -$1 ﹤0.01% 6530
2024
Q2
$122K Sell
67,952
-5,724
-8% -$16.5K ﹤0.01% 6164
2024
Q1
$351K Buy
73,676
+5,943
+9% +$20.9K ﹤0.01% 5565
2023
Q4
$196K Buy
67,733
+16
+0% +$25 ﹤0.01% 6076
2023
Q3
$91.4K Hold
67,717
﹤0.01% 6289
2023
Q2
$146K Sell
67,717
-636
-0.9% -$1.54K ﹤0.01% 6034
2023
Q1
$199K Sell
68,353
-5,852
-8% -$29.5K ﹤0.01% 5930
2022
Q4
$510K Sell
74,205
-89
-0.1% -$420 ﹤0.01% 5360
2022
Q3
$236K Buy
74,294
+5,311
+8% +$19.3K ﹤0.01% 5890
2022
Q2
$221K Buy
68,983
+36,266
+111% +$105K ﹤0.01% 6017
2022
Q1
$99K Buy
32,717
+3,440
+12% +$11.6K ﹤0.01% 6872
2021
Q4
$130K Buy
29,277
+13,863
+90% +$67.9K ﹤0.01% 6747
2021
Q3
$101K Buy
15,414
+7,302
+90% +$70K ﹤0.01% 6721
2021
Q2
$130K Buy
8,112
+7,111
+710% +$98.3K ﹤0.01% 6362
2021
Q1
$12K Hold
1,001
﹤0.01% 6979
2020
Q4
$11K Sell
1,001
-7,000
-87% -$52.6K ﹤0.01% 6702
2020
Q3
$39K Sell
8,001
-5,493
-41% -$20.8K ﹤0.01% 6100
2020
Q2
$26K Buy
13,494
+7,818
+138% +$16K ﹤0.01% 6198
2020
Q1
$11K Sell
5,676
-1,648
-23% -$5.15K ﹤0.01% 6335
2019
Q4
$33K Buy
7,324
+72
+1% +$447 ﹤0.01% 6386
2019
Q3
$59K Buy
7,252
+131
+2% +$1.43K ﹤0.01% 6255
2019
Q2
$89K Buy
7,121
+2,851
+67% +$40.3K ﹤0.01% 6066
2019
Q1
$66K Sell
4,270
-1,517
-26% -$25.1K ﹤0.01% 6084
2018
Q4
$111K Buy
5,787
+5,245
+968% +$115K ﹤0.01% 5854
2018
Q3
$17K Sell
542
-12,996
-96% -$395K ﹤0.01% 6543
2018
Q2
$360K Buy
+13,538
New +$368K ﹤0.01% 5083

Other funds holding STIM

Bank of America's STIM Position: Q1 2026 in Review

Bank of America increased its Neuronetics (STIM) stake by 6.1% in Q1 2026, buying an estimated $8.99K and bringing the position to 98,095 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #5458.

Bank of America first reported a position in STIM in Q2 2018 and has held it in 32 quarters since. The position peaked at $933K in Q1 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Bank of America held 98,095 shares of Neuronetics worth $142K as of Q1 2026.
  • Bank of America bought 5,674 Neuronetics shares in Q1 2026, an estimated $8.99K.
  • Neuronetics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5458 holding.
  • Bank of America first reported a position in Neuronetics in Q2 2018 and has held it in 32 quarters since.
  • Bank of America's Neuronetics position peaked at $933K in Q1 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.